Atgam 250 Injection 5 ml

Atgam 250 Injection 5 ml belongs to the group of medicines called immunosuppressants indicated for the prevention and treatment of acute rejection in patients receiving a kidney transplant. It may also be used to treat aplastic anaemia in patients unsuitable for bone marrow transplantation.

Atgam 250 Injection 5 ml contains antithymocyte immunoglobulin, which works by preventing the white blood cells within the immune system that are likely to attack the transplanted kidney. It helps to stop the body's immune system from rejecting the new kidney.

In some cases, Atgam 250 Injection 5 ml may cause side effects such as fever, chills, low white blood cell count, low platelet count, blood clotting problems, and skin rash. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.

Let the doctor know if you are allergic to any of the components in Atgam 250 Injection 5 ml. Consult the doctor Atgam 250 Injection 5 ml if you are pregnant. Avoid breastfeeding during treatment. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.

Atgam 250 Injection 5 ml is used in the prevention and treatment of Kidney transplant rejection and aplastic anaemia. The detailed uses of Atgam 250 Injection 5 ml are as follows:

• Prevent kidney transplant rejection: Atgam 250 Injection 5 ml is used to prevent and treat acute rejection episodes in patients who have undergone a renal (kidney) transplant, especially when other treatments are not effective.
• Treat moderate to severe aplastic anemia: Atgam 250 Injection 5 ml is prescribed for patients with aplastic anemia who are not suitable candidates for a bone marrow transplant. It helps by suppressing the immune system’s attack on bone marrow cells.
• Immunosuppressive therapy: Atgam 250 Injection 5 ml reduces the number of active T-cells in the body. This makes it useful in conditions where immune suppression is required to protect transplanted organs or manage autoimmune condition.

• Follow your doctor's instructions on the dosage and timing of this medication.
• Atgam 250 Injection 5 ml will be administered by a healthcare professional.
• Do not self-administer it.

Atgam 250 Injection 5 ml belongs to the group of medicines called immunosuppressants indicated for preventing and treating acute rejection in patients receiving a kidney transplant. It may also be used to treat aplastic anaemia in patients unsuitable for bone marrow transplantation. Atgam 250 Injection 5 ml contains Antithymocyte immunoglobulin, which lowers certain cells within the immune system that are likely to attack the transplanted kidney. It helps to stop the body's immune system from rejecting the new kidney.

Do not use Atgam 250 Injection 5 ml if you are allergic to any of its components. Inform the doctor if you have any active infection. Consult the doctor if you are pregnant or think you may be pregnant. Avoid/discontinue breastfeeding during treatment with Atgam 250 Injection 5 ml. Seek medical attention if you experience symptoms of cytokine release syndrome (fever, chills, headache, chest pain, low blood pressure, shortness of breath, fast breathing, and swelling), infusion-associated reactions (generalised rash, fast heart rate, shortness of breath, and low blood pressure), or serum sickness (rash, joint pain, fever, chills, and pain). Let the doctor know if you are taking any other medicines, including supplements and herbal products.